| ²é¿´: 86 | »Ø¸´: 2 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
xufundÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
|
[½»Á÷]
[ÇóÖú]ÇóÒ»±¾ÍâÎÄÊé
|
||
|
ÇóÍâÎÄÊéÒ»±¾¡£Ð»Ð» Drug Discovery and Development, Drug Discovery Publisher: Wiley-Interscience Number Of Pages: 476 Publication Date: 2006-06-16 Sales Rank: 399764 ISBN / ASIN: 0471398489 EAN: 9780471398486 Binding: Hardcover Manufacturer: Wiley-Interscience Studio: Wiley-Interscience Average Rating: 0 Total Reviews: 0 -------------------------------------------------------------------------------- Book Description: This two volume set provides a comprehensive account of the entire sequence of operations involved in discovering a drug through the actual delivery of the drug to clinicians and medical practitioners. Includes case studies of the discovery of erythromycin analogs (antibiotics), Tagamet, and Ultiva (remifentanil) Discusses the discovery of agents for the treatment and management of bacterial infections, Parkinson's disease, psoriasis, ulcers and stomach pain, atopic dermatitis, asthma, and cancer Contains chapters on combinatorial chemistry, molecular biology-based drug discovery, genomics, and chemogenomics The first volume of this set thoroughly describes conceptualizing a drug, creating a library of candidates for testing, screening those candidates for in vitro and in vivo activity, conducting and analyzing the results of clinical trials, and revising the drug as necessary. |
» ²ÂÄãϲ»¶
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ4È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ6È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ4È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ5È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ5È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ8È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ8È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ10È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ6È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ6È˻ظ´
xufund
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 18237.5
- É¢½ð: 20
- ºì»¨: 5
- Ìû×Ó: 6734
- ÔÚÏß: 811.7Сʱ
- ³æºÅ: 311488
- ×¢²á: 2006-12-30
- רҵ: ºÏ³ÉÒ©Îﻯѧ
Õâ±¾ÊéºÃÏñÊÇϵÁгö°æµÄ£¬ÎÒÔÚÍøÉÏËѵ½µÄÊǾí1¡£ÄãµÄÄÜ·ñ¸øÎÒÒ»·Ý£¨xufund@163.com)£¿Ð»Ð»£¡ |
3Â¥2008-04-24 17:24:28
xiananxue
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 5021.3
- É¢½ð: 58
- ºì»¨: 3
- Ìû×Ó: 1721
- ÔÚÏß: 189.2Сʱ
- ³æºÅ: 304967
- ×¢²á: 2006-12-09
- ÐÔ±ð: GG
- רҵ: Ò©Îﻯѧ
|
ÎÒÓÐÕâ±¾£¬µ«ÐÅÏ¢Óе㲻¶Ô£¬Ä㿴һϠHardcover: 456 pages Publisher: Wiley-Interscience (June 16, 2006) Language: English ISBN: 0471398489 Product Dimensions: 10.1 x 7.3 x 1.1 inches This two volume set provides a comprehensive account of the entire sequence of operations involved in discovering a drug through the actual delivery of the drug to clinicians and medical practitioners. Includes case studies of the discovery of erythromycin analogs (antibiotics), Tagamet, and Ultiva (remifentanil) Discusses the discovery of agents for the treatment and management of bacterial infections, Parkinson's disease, psoriasis, ulcers and stomach pain, atopic dermatitis, asthma, and cancer Contains chapters on combinatorial chemistry, molecular biology-based drug discovery, genomics, and chemogenomics The first volume of this set thoroughly describes conceptualizing a drug, creating a library of candidates for testing, screening those candidates for in vitro and in vivo activity, conducting and analyzing the results of clinical trials, and revising the drug as necessary |
2Â¥2008-04-24 15:47:34













»Ø¸´´ËÂ¥